Panje Cédric M, Glatzer Markus, Sirén Charlotta, Plasswilm Ludwig, Putora Paul M
Cédric M. Panje, Markus Glatzer, Ludwig Plasswilm, and Paul M. Putora, Kantonsspital St Gallen; Charlotta Sirén, Institute of Technology Management, University of St Gallen, St Gallen; and Ludwig Plasswilm and Paul M. Putora, University of Bern, Bern, Switzerland.
JCO Clin Cancer Inform. 2018 Dec;2:1-10. doi: 10.1200/CCI.18.00017.
Multiple treatment strategies exist for many oncologic problems. In this review, we provide a summary of various reasons for the existence of multiple treatment options in oncology, including factors that concern the treating physician (eg, treatment preferences), environmental factors (eg, financial, regulatory, and scientific aspects), and individual patient-specific factors (eg, medical condition, preferences). We demonstrate the vital role of available treatment options and their origins for clinical decision making and patient communication. These aspects are particularly helpful in the process of shared decision making, which is increasingly favored in situations where there are multiple medically reasonable options.
针对许多肿瘤问题存在多种治疗策略。在本综述中,我们总结了肿瘤学中存在多种治疗选择的各种原因,包括与治疗医生相关的因素(如治疗偏好)、环境因素(如财务、监管和科学方面)以及个体患者特异性因素(如医疗状况、偏好)。我们展示了可用治疗选择及其来源在临床决策和患者沟通中的重要作用。这些方面在共同决策过程中特别有帮助,在存在多种医学上合理选择的情况下,共同决策越来越受到青睐。